Abiopharma

News list

(19% Negative) Atara Biotherapeutics, Inc. (ATRA) Announces Clinical Trial Timeline Adjustment

Full text

News bot Oct. 1, 2025, 9:24 p.m.
📋 Atara Biotherapeutics, Inc. (ATRA) - Clinical Trial Update

Filing Date: 2022-05-19

Accepted: 2022-05-19 16:05:43

Event Type: Clinical Trial Update
Event Details:
Atara Biotherapeutics Inc (ATRA) Announces Clinical Trial Update Atara Biotherapeutics Inc (ATRA) provided an update on its clinical development programs. Clinical Development Highlights:
Update Type: Trial Timeline Adjustment
Primary Factors: Regulatory Process
Collaboration: Atara Biotherapeutics, Inc.
anticipated IND for ATA3271
targeting mesothelin (“Licensed Products”). The termination is effective as of September 13, 2022
💼 Business Developments:
- Partnership
- Acquisition: Not available
- Licensing
- Regulatory Approval: Not available
- Executive Changes: Not available
Structured Data:
- Company Name: Atara Biotherapeutics Inc
- CIK: 0001604464
- Ticker Symbol: ATRA
- Period End Date: 2022-05-13
- Document Type: 8-K